Literature DB >> 27605970

Recombinant human endostatin reduces hypertrophic scar formation in rabbit ear model through down-regulation of VEGF and TIMP-1.

Peng Wang1, Li-Zhu Jiang2, Bin Xue3.   

Abstract

BACKGROUND: Recombinant human endostatin (Endostar) has been widely used to suppress angiogenesis in carcinoma patients. Hypertrophic scar (HS) tissue, much like a carcinoma, is often associated with angiogenesis. However, there have been few studies conducted on the effects of Endostar on HS or its mechanism.
OBJECTIVE: This paper investigated the effects Endostar on the HS of rabbit ears and studied the effects of Endostar on VEGF and TIMP-1 expression.
METHODS: Sixteen New Zealand white rabbits were used to establish HS models. Then, rabbit ears containing HS were randomly assigned to either the Endostar group or the control group. The changes of appearance and histology were evaluated using the naked eye, hematoxylin eosin staining, and a scar elevation index. The VEGF and TIMP-1 expressions were detected by immunohistochemical staining, RT-PCR, and western blot.
RESULTS: The thickness of the connective tissue in the Endostar group were thinner, the numbers of micro vessels and fibroblasts were fewer, and the collagen fibers were smoother. Moreover, the mRNA and protein expressions of VEGF and TIMP-1 in the Endostar group were significantly lower than those in the control group.
CONCLUSION: The results suggested that Endostar reduced the formation of HS by down-regulation of VEGF and TIMP-1 expressions.

Entities:  

Keywords:  Endostar; endostatin; hypertrophic scar; tissue inhibitor of metalloproteinase-1; vascular endothelial growth factor

Mesh:

Substances:

Year:  2016        PMID: 27605970      PMCID: PMC4994545          DOI: 10.4314/ahs.v16i2.23

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  28 in total

1.  Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.

Authors:  Thaís Amadeu; André Braune; Carlos Mandarim-de-Lacerda; Luís Cristóvão Porto; Alexis Desmoulière; Andréa Costa
Journal:  Pathol Res Pract       Date:  2003       Impact factor: 3.250

Review 2.  The myofibroblast in wound healing and fibrocontractive diseases.

Authors:  G Gabbiani
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

Review 3.  The pathogenesis of hypertrophic/keloid scarring.

Authors:  D W Thomas; I Hopkinson; K G Harding; J P Shepherd
Journal:  Int J Oral Maxillofac Surg       Date:  1994-08       Impact factor: 2.789

4.  Hypoxia upregulates VEGF production in keloid fibroblasts.

Authors:  D S Steinbrech; B J Mehrara; D Chau; N M Rowe; G Chin; T Lee; P B Saadeh; G K Gittes; M T Longaker
Journal:  Ann Plast Surg       Date:  1999-05       Impact factor: 1.539

5.  Acute and chronic animal models for excessive dermal scarring: quantitative studies.

Authors:  D E Morris; L Wu; L L Zhao; L Bolton; S I Roth; D A Ladin; T A Mustoe
Journal:  Plast Reconstr Surg       Date:  1997-09       Impact factor: 4.730

6.  Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion.

Authors:  C T Ong; Y T Khoo; E K Tan; A Mukhopadhyay; D V Do; H C Han; I J Lim; T T Phan
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

7.  Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/β-catenin signaling.

Authors:  Virginia Egea; Stefan Zahler; Nicole Rieth; Peter Neth; Tanja Popp; Kai Kehe; Marianne Jochum; Christian Ries
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-05       Impact factor: 11.205

8.  TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma.

Authors:  Dietmar Ulrich; Ernst-Magnus Noah; Dennis von Heimburg; Norbert Pallua
Journal:  Plast Reconstr Surg       Date:  2003-04-01       Impact factor: 4.730

Review 9.  The treatment of hypertrophic scars and keloids.

Authors:  B Berman; F Flores
Journal:  Eur J Dermatol       Date:  1998-12       Impact factor: 3.328

10.  Endostar, a novel human recombinant endostatin, attenuates liver fibrosis in CCl4-induced mice.

Authors:  Jing Chen; Dian-Gang Liu; Guang Yang; Ling-Jian Kong; Ya-Ju Du; Hang-Yu Wang; Feng-Dong Li; Feng-Hua Pei; Ji-Tao Song; Yu-Jing Fan; Ai-Yun Liu; Xin-Hong Wang; Bao-Xin Li
Journal:  Exp Biol Med (Maywood)       Date:  2014-05-28
View more
  8 in total

Review 1.  Endostatin in Renal and Cardiovascular Diseases.

Authors:  Mei Li; Zoran Popovic; Chang Chu; Bernhard K Krämer; Berthold Hocher
Journal:  Kidney Dis (Basel)       Date:  2021-09-09

2.  [Treatment of keloids at the ear].

Authors:  Fabienne Oettgen; Frank Haubner
Journal:  Dermatologie (Heidelb)       Date:  2022-09

3.  Angiogenic gene characterization and vessel permeability of dermal microvascular endothelial cells isolated from burn hypertrophic scar.

Authors:  Esteban A Molina; Brandon Hartmann; Mary A Oliver; Liam D Kirkpatrick; John W Keyloun; Lauren T Moffatt; Jeffrey W Shupp; Taryn E Travis; Bonnie C Carney
Journal:  Sci Rep       Date:  2022-07-18       Impact factor: 4.996

Review 4.  Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.

Authors:  Ho Jun Lee; Yong Ju Jang
Journal:  Int J Mol Sci       Date:  2018-03-02       Impact factor: 5.923

Review 5.  Strategies to prevent hypertrophic scar formation: a review of therapeutic interventions based on molecular evidence.

Authors:  Eri Shirakami; Sho Yamakawa; Kenji Hayashida
Journal:  Burns Trauma       Date:  2020-01-27

Review 6.  Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury.

Authors:  Zengfu Zhang; Jialin Zhou; Vivek Verma; Xu Liu; Meng Wu; Jinming Yu; Dawei Chen
Journal:  Front Immunol       Date:  2021-12-01       Impact factor: 7.561

Review 7.  A Systematic Review Comparing Animal and Human Scarring Models.

Authors:  Riyam Mistry; Mark Veres; Fadi Issa
Journal:  Front Surg       Date:  2022-04-22

Review 8.  In Vivo Models for Hypertrophic Scars-A Systematic Review.

Authors:  Stefan Rössler; Sebastian Philipp Nischwitz; Hanna Luze; Judith C J Holzer-Geissler; Robert Zrim; Lars-Peter Kamolz
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.